FTC divided on whether it can challenge drug-price spikes under existing law
The Federal Trade Commission split over whether it could challenge drug-price spikes — such as the price of insulin, which has increased from $35 a vial to as much as $540...To view the full article, register now.
Already a subscriber? Click here to view full article